Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1984;70:297-302

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fitzgerald, D. J.
Right arrow Articles by FitzGerald, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fitzgerald, D. J.
Right arrow Articles by FitzGerald, G. A.

Circulation, Vol 70, 297-302, Copyright © 1984 by American Heart Association


ARTICLES

The effects of organic nitrates on prostacyclin biosynthesis and platelet function in humans

DJ Fitzgerald, L Roy, RM Robertson and GA FitzGerald

The results of prior studies indicate that nitroglycerin stimulates prostacyclin release by cultured endothelium and by the coronary vasculature in vivo. However, the accuracy of these findings in coronary vasculature relies on plasma samples obtained from the circulation via cardiac catheters, a procedure we have shown to stimulate prostacyclin release, thereby confounding interpretation of drug action. We studied the effects of short-acting (nitroglycerin) and long-acting (isosorbide dinitrate) nitrates on a noninvasive index of prostacyclin synthesis, excretion of urinary 2,3-dinor-6-keto-PGF1 alpha. Nitroglycerin was infused into six subjects to either a maximum of 480 micrograms/min or until mean arterial pressure fell by 20 mm Hg. Urine was collected for negative ion chemical ionization gas chromatographic, mass spectrometric analysis before and during the nitroglycerin infusion and for two 2 hr periods after nitroglycerin. The peak nitroglycerin infusion rate was 387 +/- 67 micrograms/min, which caused a fall in supine blood pressure (systolic/diastolic) of 11 +/- 5/14 +/- 4 mm Hg and a 12 +/- 3 beats/min increase in heart rate. Excretion of 2,3-dinor-6-keto-PGF1 alpha (pg/mg creatinine) was unchanged from control infusion values (106 +/- 19.5) either during (123 +/- 21) or after (134 +/- 14.6; 139 +/- 36) nitroglycerin infusion. Platelet aggregation to arachidonic acid (0.33 to 1.33 microM) and epinephrine (1 to 10 microM) ex vivo was inhibited in only one subject in whom excretion of 2,3-dinor-6-keto-PGF1 alpha was unaltered. Serum thromboxane B2 was not changed by nitroglycerin infusion.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
CirculationHome page
G. Vilahur, E. Segales, E. Salas, and L. Badimon
Effects of a Novel Platelet Nitric Oxide Donor (LA816), Aspirin, Clopidogrel, and Combined Therapy in Inhibiting Flow- and Lesion-Dependent Thrombosis in the Porcine Ex Vivo Model
Circulation, September 21, 2004; 110(12): 1686 - 1693.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
A Jain, V Wadehra, and A D Timmis
Management of stable angina
Postgrad. Med. J., June 1, 2003; 79(932): 332 - 336.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Z. Kaposzta, P. A. Baskerville, D. Madge, S. Fraser, J. F. Martin, and H. S. Markus
L-Arginine and S-Nitrosoglutathione Reduce Embolization in Humans
Circulation, May 15, 2001; 103(19): 2371 - 2375.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
Y. Yeghiazarians, J. B. Braunstein, A. Askari, and P. H. Stone
Unstable Angina Pectoris
N. Engl. J. Med., January 13, 2000; 342(2): 101 - 114.
[Full Text] [PDF]


Home page
CirculationHome page
J. Molloy, J. F. Martin, P. A. Baskerville, S. C. A. Fraser, and H. S. Markus
S-Nitrosoglutathione Reduces the Rate of Embolization in Humans
Circulation, October 6, 1998; 98(14): 1372 - 1375.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
S. C. Body and S. K. Shernan
The Utility of Nitric Oxide in the Postoperative Period
Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 1998; 2(1): 4 - 30.
[Abstract] [PDF]


Home page
CirculationHome page
C. J. Knight, M. Panesar, D. J. Wilson, N. A.F. Chronos, D. Patel, K. Fox, and A. H. Goodall
Different Effects of Calcium Antagonists, Nitrates, and ß-Blockers on Platelet Function: Possible Importance for the Treatment of Unstable Angina
Circulation, January 7, 1997; 95(1): 125 - 132.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
E.J. Langford, R.J. Wainwright, and J.F. Martin
Platelet Activation in Acute Myocardial Infarction and Unstable Angina Is Inhibited by Nitric Oxide Donors
Arterioscler. Thromb. Vasc. Biol., January 1, 1996; 16(1): 51 - 55.
[Abstract] [Full Text]


Home page
CirculationHome page
Z. Kaposzta, J. F. Martin, and H. S. Markus
Switching off Embolization From Symptomatic Carotid Plaque Using S-Nitrosoglutathione
Circulation, March 26, 2002; 105(12): 1480 - 1484.
[Abstract] [Full Text] [PDF]